Hartmann Miriam, Lanham Michele, Palanee-Phillips Thesla, Mathebula Florence, Tolley Elizabeth E, Peacock Dean, Pascoe Laura, Zissette Seth, Roberts Sarah T, Wagner Danielle, Wilson Ellen, Ayub Asha, Wilcher Rose, Montgomery Elizabeth T
Women's Global Health Imperative, RTI International, San Francisco, California.
FHI 360, Durham, North Carolina.
AIDS Educ Prev. 2019 Oct;31(5):433-451. doi: 10.1521/aeap.2019.31.5.433.
This article describes the development of the Community Health clinic model for Agency in Relationships and Safer Microbicide Adherence intervention (CHARISMA), an intervention designed to address the ways in which gender norms and power differentials within relationships affect women's ability to safely and consistently use HIV pre-exposure prophylaxis (PrEP). CHARISMA development involved three main activities: (1) a literature review to identify appropriate evidence-based relationship dynamic scales and interventions; (2) the analysis of primary and secondary data collected from completed PrEP studies, surveys and cognitive interviews with PrEP-experienced and naïve women, and in-depth interviews with former vaginal ring trial participants and male partners; and (3) the conduct of workshops to test and refine key intervention activities prior to pilot testing. These steps are described along with the final clinic and community-based intervention, which was tested for feasibility, acceptability, and preliminary effectiveness in Johannesburg, South Africa.
本文介绍了关系与安全杀微生物剂依从性干预机构社区健康诊所模式(CHARISMA)的发展情况,该干预旨在解决关系中的性别规范和权力差异影响女性安全、持续使用艾滋病毒暴露前预防(PrEP)能力的方式。CHARISMA的发展涉及三项主要活动:(1)文献综述,以确定合适的基于证据的关系动态量表和干预措施;(2)分析从已完成的PrEP研究、对有PrEP经验和无经验女性的调查及认知访谈以及对前阴道环试验参与者和男性伴侣的深入访谈中收集的初级和二级数据;(3)举办研讨会,在试点测试之前对关键干预活动进行测试和完善。这些步骤以及最终基于诊所和社区的干预措施均有描述,该干预措施在南非约翰内斯堡进行了可行性、可接受性和初步有效性测试。